Table 1 Baseline clinical characteristics of study patients
Variable | Group 1 | Group 2 | Group 3 | p value |
|---|---|---|---|---|
(N = 73) | (N = 146) | (N = 29) | ||
Age (years) | 60 ± 9 | 60 ± 10 | 61 ± 10 | 0.885 |
Males (%) | 56 (77) | 118 (81) | 23 (79) | 0.777 |
Hypertension (%) | 39 (53) | 56 (38) | 16(55) | 0.052 |
Diabetes mellitus (%) | 8 (11) | 26 (18) | 7 (24) | 0.220 |
Heart failure (%) | 19 (26) | 22 (15) | 12(41) | 0.004 |
Previous stroke/TIA (%) | 1 (1) | 18 (7) | 2 (7) | 0.022 |
Previous MI/CAD (%) | 4 (5) | 10 (7) | 2 (7) | 0.652 |
C-V score | 1.6 ± 1.0 | 1.6 ± 1.4 | 2.1 ± 1.4 | 0.174 |
Hyperthyroidism (%) | 9 (12) | 11(8) | 1(3) | 0.285 |
LVEF (%) | 59 ± 9 | 59 ± 8 | 54 ± 13 | 0.021 |
LVEF < 40% (%) | 5 (7) | 5 (3) | 4 (14) | 0.067 |
LA diameter (mm) | 45 ± 6 | 45 ± 6 | 47 ± 6 | 0.415 |
LA volume index | 44 ± 19 | 41 ± 20 | 45 ± 23 | 0.410 |
LV mass index | 85 ± 34 | 77 ± 32 | 81 ± 33 | 0.317 |
TEE | 71 (97) | 140 (97) | 27 (93) | 0.717 |
HR on ECG | 85 ± 17 | 84 ± 17 | 84 ± 15 | 0.819 |
HR on Holter | 85 ± 15 | 79 ± 17 | 78 ± 12 | 0.138 |
Cardiac size (mm) | 155 ± 17 | 157 ± 15 | 164 ± 18 | 0.029 |
Cardiothoracic ratio | 0.52 ± 0.06 | 0.52 ± 0.57 | 0.54 ± 0.06 | 0.347 |